Natural exosomes-like nanoparticles in mung bean sprouts possesses anti-diabetic effects via activation of PI3K/Akt/GLUT4/GSK-3β signaling pathway
Open Access
- 28 September 2023
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 21 (1) , 1-17
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia and insulin resistance. Mung bean sprouts are traditionally considered a “folk” hypoglycemic food and their pharmacological effects and underlying mechanisms warrant further investigation. Purpose: This study aimed to investigate the anti-diabetic effects of the exosomes-like nanoparticles in mung bean sprouts (MELNs) and explore the related molecular mechanisms. Results: MELNs were isolated using a differential centrifugation-polyethylene glycol (PEG) method, and the identification of MELNs were confirmed by PAGE gel electrophoresis, agarose gel electrophoresis, thin-layer chromatography (TLC), and transmission electron microscopy (TEM). In the high-fat diet/streptozotocin (HFD/STZ) mouse model, MELNs ameliorated the progression of T2DM by increasing oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) results, decreasing the fasting blood glucose level, and reducing the serum triglycerides (TG) and total cholesterol (TC). Histopathological examinations indicated MELNs diminished inflammatory infiltration of hepatocytes and amplified the area of islet B cells. In addition, MELNs decreased the oxidative stress levels in liver tissue and had good biocompatibility. In vitro experiments verified that MELNs improved the viability of glucosamine (GlcN) induced insulin-resistant hepatocytes. Furthermore, this study also revealed that MELNs upregulated GLUT4 & Nrf2 and down-regulated GSK-3β via activating the PI3K/Akt signaling pathway, promoting the production of antioxidant enzymes, such as HO-1 and SOD, to reduce oxidative stress. Conclusion: MELNs mitigated the progression of type 2 diabetes in HFD/STZ mouse model. The underlying molecular mechanism is related to PI3K/Akt/GLUT4/GSK-3β signaling pathway.Keywords
Funding Information
- Sichuan Provincial Administration of Traditional Chinese Medicine (2021MS464, 2021MS464, 2021MS464, 2021MS464, 2021MS464, 2021MS464, 2021MS464, 2021MS464, 2021MS464, 2021MS464, 2021MS464)
This publication has 53 references indexed in Scilit:
- Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 DiabetesDiabetes Care, 2011
- Pathways and mechanisms of endocytic recyclingNature Reviews Molecular Cell Biology, 2009
- SIRT1 Improves Insulin Sensitivity under Insulin-Resistant Conditions by Repressing PTP1BCell Metabolism, 2007
- Involvement of Oxidative Stress in the Pathogenesis of DiabetesAntioxidants & Redox Signaling, 2007
- Endocytosis, intracellular sorting, and processing of exosomes by dendritic cellsBlood, 2004
- Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative StressMolecular and Cellular Biology, 2003
- A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated ratMetabolism, 2000
- Role of impaired intracellular glucose metabolism in the insulin resistance of agingMetabolism, 1992
- Late endosomes derive from early endosomes by maturationCell, 1991
- Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle.Journal of Clinical Investigation, 1990